Colgate-Palmolive (CL) is a publicly traded Consumer Defensive sector company. As of November 15, 2026, CL trades at $99.67 with a market cap of $79.23B and a P/E ratio of 34.21. CL moved +1.81% today. Year to date, CL is +29.56%; over the trailing twelve months it is +26.50%. Its 52-week range spans $74.55 to $101.18. Analyst consensus is buy with an average price target of $102.25. Rallies surfaces CL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
US EPA, Colgate-Palmolive reach settlement over large-quantity chemical imports: The U.S. EPA said it reached a settlement with Colgate-Palmolive to bring the company into compliance with requirements for large-quantity chemical imports.
| Metric | Value |
|---|---|
| Price | $99.67 |
| Market Cap | $79.23B |
| P/E Ratio | 34.21 |
| EPS | $2.55 |
| Dividend Yield | 0.53% |
| 52-Week High | $101.18 |
| 52-Week Low | $74.55 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.05B |
| Net Income | $2.16B |
| Gross Margin | 60.42% |
12 analysts cover CL: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $102.25.